MiLaboratories is hosting the next High-Affinity Talks featuring Konrad Krawczyk, Founder of NaturalAntibody, to break down AI/ML in workflows and address data scarcity in biologics discovery.
Published
Signal category
Presence & Recognition
Quote
“Our next High-Affinity Talks features someone you all know well: Konrad Krawczyk, Founder of NaturalAntibody, who will break down the reality of AI/ML in our workflows and address the data scarcity problem.”
— Stanislav Poslavsky|MiLaboratories team
Company
MiLaboratories
The next-gen software for biologics discovery
- Industry
- Biotechnology Research
- Location
- San Francisco, US
- Company size
- 25 employees
We’re building the operating system for biology. Founded by scientists, our mission is to transform how R&D teams turn raw NGS data into therapeutic assets. By bridging the gap between biology and bioinformatics, we empower scientists to drive innovation without technical barriers. Our software, Platforma, combines an intuitive, no-code interface with white-box solutions tailored for in vivo and in vitro antibody discovery, translational research, and multi-omics. Built on the proven foundation of MiXCR, the world's leading immune profiling tool, we provide your R&D team with the unified intelligence to accelerate discovery and bring therapeutics to market faster.
Founded 2021